AccessPak for HIV PEP Basic and Bupropion Hydrochloride

• Generic Name: emtricitabine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: AccessPak for HIV PEP Basic, Descovy, Truvada

AccessPak for HIV PEP Basic are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body.

AccessPak for HIV PEP Basic is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). AccessPak for HIV PEP Basic is not a cure for HIV or AIDS, but it can be used to treat HIV in adults and children who are at least 12 years old and weigh at least 17 kilograms (37 pounds).

AccessPak for HIV PEP Basic is also used in children who weigh between 55 and 77 pounds (25 to 35 kilograms) and who take certain other HIV medications.

Truvada PrEP is used together with safer-sex practices to reduce the risk of becoming infected with HIV. You must be HIV-negative and an adult to use Truvada PrEP for this purpose.

AccessPak for HIV PEP Basic may also be used for purposes not listed in this medication guide.

• Generic Name: bupropion
• Dosage Forms: n.a.
• Other Brand Names: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL

Treatment of major depressive disorder.

May be useful (alone or in combination with other antidepressants) in patients with refractory depression.

Seasonal Affective Disorder

Prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD; also referred to as winter depression).

Smoking Cessation

Adjunct in the cessation of smoking (alone or in combination with nicotine replacement therapy).

US Public Health Service (USPHS) guideline for the treatment of tobacco use and dependence recommends bupropion (as extended-release tablets) as one of several first-line drugs that may reliably increase long-term smoking abstinence rates.

Depression Associated with Bipolar Disorder

Treatment of patients with bipolar depression (bipolar disorder, depressive episode).

American Psychiatric Association (APA) considers bupropion one of several second-line agents for use when first-line agents are ineffective or not tolerated.

Attention Deficit Hyperactivity Disorder (ADHD)

Used in a limited number of children and adults in the management of ADHD.

Panic Disorder

Ineffective in the treatment of panic disorder and concomitant phobic disorder, but may improve symptoms of panic and depression in patients with major depression who have superimposed panic symptoms.

Bulimia Nervosa

Not recommended by APA for bulimia nervosa because associated with seizures in purging bulimic patients.